PUBLISHER: Grand View Research | PRODUCT CODE: 1941530
PUBLISHER: Grand View Research | PRODUCT CODE: 1941530
The global colon screening market size was estimated at USD 40.41 billion in 2025 and projected to reach USD 57.65 billion by 2033, growing at a CAGR of 4.60% from 2026 to 2033. The growing prevalence of colorectal cancer, increasing government initiatives to encourage cancer screening, and ongoing technological advancements in the market are major factors driving the growth of this market.
For instance, in December 2023, Medtronic expanded its artificial intelligence collaboration with Cosmo Pharmaceuticals, the developer of plug-in software designed to detect health issues during endoscopic examinations automatically.
The increasing prevalence of colorectal diseases is a major driver of growth in the colon screening industry. Colorectal cancer, a severe gastrointestinal condition, ranks as the third most commonly diagnosed cancer and the second leading cause of cancer-related deaths worldwide. Its growing incidence highlights the critical need for early detection and effective screening methods. According to the International Agency for Research on Cancer (IARC), approximately 1.9 million new cases of colorectal cancer are reported annually across the globe, making it one of the most prevalent malignancies. The World Health Organization further emphasizes that regions such as Europe, Australia, and New Zealand exhibit the highest incidence rates, primarily due to lifestyle factors, diet, and aging populations.
Global Colon Screening Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides the analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global colon screening market report based on type, end use, and region: